Viewing Study NCT04507906


Ignite Creation Date: 2025-12-26 @ 5:23 PM
Ignite Modification Date: 2025-12-26 @ 5:23 PM
Study NCT ID: NCT04507906
Status: COMPLETED
Last Update Posted: 2022-06-28
First Post: 2020-08-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC
Sponsor: Shanghai Chest Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module